Urodynamic profile in posterior urethral valve patients following fulguration: Does age at fulguration matter?

Ashwin Mallya1, Vilvapathy Senguttuvan Karthikeyan1, Sundaramoorthy Vijayganapathy1

  • 1Department of Urology, Institute of Nephro Urology, Bengaluru, Karnataka, India.

Insights

Children with posterior urethral valve (PUV) who underwent valve fulguration (VF) at a younger age (<2 years) showed better bladder function. Longer time since VF also correlated with increased urinary bladder dysfunction in PUV patients.

Area of Science:

  • Pediatric Urology
  • Urodynamics
  • Bladder Dysfunction

Background:

  • Posterior urethral valve (PUV) can lead to urinary bladder (UB) dysfunction post-valve fulguration (VF).
  • Urodynamics (UDS) is crucial for assessing UB function in these children.

Purpose of the Study:

  • To investigate the impact of age at VF and time elapsed since VF on UB dysfunction in PUV patients.
  • To identify risk factors for persistent or developing bladder issues after PUV treatment.

Main Methods:

  • Retrospective analysis of 39 PUV patients undergoing UDS between 2009-2016.
  • Patients were grouped by age at VF (<2 years vs. ≥2 years) and time since VF (≤4 years vs. >4 years).

Main Results:

  • Reduced bladder compliance was observed in 67% of patients, with detrusor overactivity in 38.5% and 15.4% experiencing leaks.
  • Younger age at VF (<2 years) was associated with better urodynamic profiles.
  • Increased time since VF correlated with a higher incidence of bladder dysfunction.

Conclusions:

  • Early valve fulguration (<2 years) in PUV patients is linked to improved long-term bladder function.
  • The duration of time after valve fulguration is a significant factor in the development of urinary bladder dysfunction.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
237
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
4.3K
Classifying Matter by State02:49

Classifying Matter by State

Chemistry is the study of matter and the changes it undergoes. Matter is anything that has mass and occupies space. Matter is all around us; the air, water, soil, mountains, even our bodies are all examples of matter. Matter is divided into three states — solid, liquid, and gas — that are commonly found on earth. The fourth state of matter, plasma, occurs naturally in the interiors of stars. 
103.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215